Delivery Order SPE2DB22D2006-SPE2DB24FW1BJ
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.04 firm fixed-price contract is for the delivery of 4,566,754,908 units of 20mg Simvastatin tablets, a cardiovascular medication, with a completion date of December 19, 2024. This award is part of an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This federal contract award for $1,079.94 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of 1,000 units of 20 mg Simvastatin tablets. The contract has an ultimate completion date of February 2, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,396.18 firm fixed-price delivery order is for 4,562,345,313 units of 10 mg Simvastatin tablets. The contract has an ultimate completion date of September 29, 2023 and is not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.12 firm fixed-price delivery order is for 4,565,020,548 tablets of Simvastatin 40 mg, a cardiovascular medication. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,804.76 firm fixed-price delivery order is for the supply of 4,566,205,526 units of the generic drug Simvastatin 40mg tablets. The award has an ultimate completion date of October 28, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $2,224.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,565,239,896 units of Simvastatin 20 mg tablets and has a firm fixed-price pricing type. The award was not associated with any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,005.88 firm-fixed-price delivery order (SPE2DB20D1004|SPE2DB23FG3J6) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for 4,561,708,082 units of Simvastatin 20 mg tablets. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Simvastatin 40 mg tablets. The contract has a firm fixed price of $1,504.93 and a period of performance through May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.16 firm fixed-price delivery order contract is for the supply of 4,566,948,919 units of Simvastatin 20 mg tablets. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a $1,243.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,560,703,374 Simvastatin 40 mg tablets. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW1BJDelivery Order
This federal contract award, with an ID of SPE2DB22D2006|SPE2DB24FW1BJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,886,261 units of 40mg Simvastatin tablets, a cardiovascular medication, with a ceiling value of $4,264.80. The contract is a Firm Fixed Price Delivery Order with a performance period ending on June 13, 2024. Amerisourcebergen Drug Corp, the prime contractor, does not have any major subcontractors listed for this specific award. However, the company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. The contract award was not designated with any set-aside requirements, indicating open competition. This contract supports the DLA's role in providing essential pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 6/12/24 |